BGY vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard shows a strong Piotroski F-Score of 7/9, indicating solid financial health, but the absence of an Altman Z-Score limits distress risk assessment. Despite high profitability margins and strong historical price performance, the stock trades at a steep valuation (P/E 45.92 vs. sector avg 31.01) with declining revenue and an unsustainable dividend payout ratio of 366.15%. Technical trend is deeply bearish (10/100), and lack of analyst coverage further increases uncertainty. These factors outweigh the strong F-Score and high yield, leading to a bearish outlook.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
BGY vs JPM: Head-to-Head Comparison
This page compares BlackRock Enhanced International Dividend Trust (BGY) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.